Position in ALKS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$11,107
+$3,929 QoQ
Shares Held
212
+4.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#356
of 421 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Davis Capital Management holds $13,097 across 13 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (84.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
212 | $11,107 | |
| 2 | ZTS |
Zoetis Inc.
|
8 | $574 | |
| 3 | LQDA |
Liquidia Corp
|
4 | $318 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
7 | $287 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
10 | $173 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
3 | $141 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3 | $139 | |
| 8 | PRGO |
PERRIGO Co plc
|
8 | $83 |
All Filings in ALKS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,107 | 212 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $7,178 | 203 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $5,679 | 203 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $6,090 | 203 | Shares | Sole | 2025-10-21 | |
| 2025-03-31 | $6,703 | 203 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $5,838 | 203 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $5,681 | 203 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $4,892 | 203 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $5,495 | 203 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $5,631 | 203 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||